Search

Search Results

• CO:06:3 | Clinical and laboratory markers for distinguishing VEXAS from Schnitzler's syndrome in male patients with skin involvement: insights from the International AIDA Network Registries Valeria Caggiano¹, Jessica Sbalchiero¹, Micol Frassi², Andrea Hinojosa-Azaola³, Francesca Crisafulli², Franco Franceschini², Paolo Sfriso⁴, Sara Bindoli⁴, José Hernández-Rodríguez⁵, Henrique A. Mayrink Giardini⁶, Giuseppe Lopalco⁷, Florenzo Iannone⁷, Ombretta Viapiana⁸, Amato De Paulis⁹, Lorenzo Dagna¹⁰, Antonio Gidaro¹¹, Serena Bugatti¹², Matteo Piga¹³, Fabrizio Conti¹⁴, Rosetta Vitetta¹⁵, Cecilia Chighizola¹⁶, Marcello Govoni¹⁷, Giacomo Emmi¹⁸, Paola Triggianese¹⁹, Carmelo Gurnari¹⁹, Bruno Frediani¹, Claudia Fabiani¹, Luca Cantarini¹, Antonio Vitale¹, for the AIDA Network¹ | ¹Department of Medical Sciences, Surgery and Neurosciences, University of Siena; ²University of Brescia, Italy; ³Department of Immunology and Rheumatology, Mexico City, Mexico; ⁴Rheumatology Unit, University of Padova, Italy; ⁵Clinical Unit of Autoinflammatory Diseases, Hospital Clínic of Barcelona, Spain; ⁶Rheumatology Division, Universidade de São Paulo, Brazil; ⁷University of Bari; ⁸Rheumatology Unit, University and Azienda Ospedaliera Universitaria Integrata of Verona; ⁹University of Napoli "Federico II"; ¹⁰Università Vita-Salute San Raffaele, Milano; ¹¹Luigi Sacco Hospital, University of Milano; ¹²Università di Pavia; ¹³University and AOU of Cagliari; ¹⁴AOU Policlinico Umberto I, Sapienza University of Rome; ¹⁵Unit of Rheumatology, ASL Sant' Andrea Hospital, Vercelli; ¹⁶University of Milano; ¹⁷Azienda Ospedaliero-Universitaria S. Anna, Ferrara; ¹⁸University of Trieste; ¹⁹University of Rome-Tor Vergata, Rome, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1975

  188

• PO:19:279 | Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry Jessica Sbalchiero¹, Antonio Vitale¹, Valeria Caggiano¹, Abdurrahman Tufan², Ezgi Batu³, Gaafar Ragab⁴, Seza Ozen³, Jurgen Sota¹, Carla Gaggiano¹, Ali Sahin⁵, Petros Sfikakis⁶, Francesca Li Gobbi⁷, Giacomo Emmi⁸, Jose Rodriguez⁹, Piero Ruscitti¹⁰, Paolo Sfriso¹¹, Ewa Szewczyk¹², Giuseppe Lopalco¹³, Alberto Balistreri¹⁴, Claudia Fabiani¹⁵, Bruno Frediani¹, Luca Cantarini¹ | ¹Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy; ²Department of Internal Medicine, Division of Rheumatology, Gazi University Hospital Ankara, Turkey; ³Division of Pediatric Rheumatology, Department of Pediatrics, Hacettepe University School of Medicine Ankara, Turkey; ⁴Internal Medicine Department, Rheumatology and Clinical Immunology Unit, Faculty of Medicine, Cairo University Giza, Egypt; ⁵Division of Rheumatology, Department of Internal Medicine, Sivas Cumhuriyet University Medical Faculty Sivas, Turkey; ⁶Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens Athens, Greece; ⁷Rheumatology Unit, Hospital S. Giovanni di Dio, Azienda USL-Toscana Centro Florence, Italy; ⁸Clinical Medicine and Rheumatology Unit, Cattinara University Hospital Trieste, Italy; ⁹Department of Autoimmune Diseases, Institut Investigacions Biomediques August Pi I Sunyer, University of Barcelona Barcelona Spain; ¹⁰Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy; ¹¹Rheumatology Unit, Department of Medicine, University of Padua Padua, Italy; ¹²7Department of Internal Medicine, Pneumonology, Allergology, Clinical Immunology and Rare Diseases, Military Institute o Warsaw, Poland; ¹³Department of Precision and Regenerative Medicine and Ionian Area DiMePRe-J Policlinic Hospital, University of Bari Bari, Italy; ¹⁴Bioengineering and Biomedical Data Science Lab, Department of Medical Biotechnologies, University of Siena Siena, Italy; ¹⁵Ophthalmology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena Siena, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2339

  28

• PO:04:054 | Clinical efficacy and drug retention rate of upadacitinib in patients with axial spondyloarthritis: results from a single-center observational study Simona Buonanno¹, Carla Gaggiano¹, Caterina Baldi¹, Marco Bardelli¹, Cristiana Barreca¹, Francesca Bellisai¹, Marta Fabbroni¹, Paolo Falsetti¹, Anna Paola Pata¹, Enrico Selvi¹, Jurgen Sota¹, Antonio Vitale¹, Luca Cantarini¹, Bruno Frediani¹, Stefano Gentileschi¹ | U.O.C. Reumatologia, Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze, Università di Siena, A.O.U. Senese, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2130

  146